Biotek-snakken — Februar 2026
-
Egetis Completes the U.S. Rolling NDA Submission for Emcitate® (tiratricol) for Treatment of MCT8 Deficiency - Egetis Therapeutics
Priority Review and Rare Pediatric Disease Priority Review Voucher requested Anticipated regulatory decision in September 2026 Emcitate® (tiratricol) U.S. launch expected in Q4 2026, if approved Stockholm, Sweden, January 29, 2026. Egetis Therapeutics AB (publ) (“Egetis” or the “Company”) (NASDAQ Stockholm: EGTX), today announced that the Company has completed the rolling New Drug Application (NDA) […]
Egetis Therapeutics (www.egetis.com)
-
Egetis Completes the U.S. Rolling NDA Submission for Emcitate
(tiratricol) for Treatment of MCT8 DeficiencyJanuary 29, 2026
Priority Review and Rare Pediatric Disease Priority Review Voucher requested
Anticipated regulatory decision in September 2026
Emcitate
(tiratricol) U.S. launch expected in Q4 2026, if approved -
PILA PHARMA AB (publ) (FN STO: PILA) today publishes the Company´s
year-end report for the period January – December 2025 https://cdn.bequoted.com/media/1/2e08febe-36c8-4704-bcd7-199fa6b0e831/Pila_Pharma_Pressrelease_2026-02-10.pdf -
@Darvin - Ja; Curasight ligger ikke på den lade sig - Dagens udmelding om deltagelse i TD Cowen konferencen 3. marts med pæsentation og 1-1 møder lyder spændende. De fisker efter partneraftale. https://news.cision.com/curasight/r/curasight-to-present-at-td-cowen-s-46th-annual-health-care-conference-in-boston,c4308454
-
Initiator Pharma A/S granted European patent for pudafensine in Female Sexual Dysfunction, including vulvodynia
https://www.nordnet.dk/markedet/nyheder/2eb95538-e9a8-4e13-85c7-ae0ecc7583aa -
Saniona afholder investor konference 26 Feb. https://saniona.com/newsroom/single-press-release/?slug=invitation-to-saniona-q4-and-year-end-investor-call-on-26-february-2026
-
Saniona årsrapport 2025. https://saniona.com/newsroom/press-releases/
-
Gubra tidoblede omsætningen efter milliardaftale med Abbvie https://proinvestor.com/investornyt/1415516/gubra-tidoblede-omsaetningen-efter-milliardaftale-med-abbvie
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind